Sleep

Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study.

TL;DR

Psychotropic medications alter sleep architecture in recognizably class-specific ways, and these effects compound as the number of concurrent agents grows.

Key Findings

Psychotropic medication users exhibited significantly worse overall sleep quality compared to non-users across multiple polysomnographic parameters.

  • Medicated individuals exhibited reduced sleep efficiency (p = .001) compared to the 60 non-psychotropic medication users
  • Psychotropic users showed prolonged sleep onset latency (p = .001) and prolonged REM latency (p = .001)
  • Medicated individuals also showed increased light sleep and fewer sleep cycles
  • The study compared 61 psychotropic medication users against 60 non-psychotropic medication users using hospital polysomnography data from January 2018 to December 2021

Antidepressants were specifically associated with markedly increased REM latency and increased periodic limb movements.

  • Multivariable analyses showed antidepressants markedly increased REM latency (p = .001)
  • Antidepressants were also associated with increased periodic limb movements (p = .015)
  • Analyses were adjusted for age, sex, and BMI using multivariable general linear models with HC3 robust errors
  • These findings reflect class-specific effects of antidepressants on sleep architecture

Anticonvulsants were specifically associated with enhanced slow-wave sleep.

  • Multivariable analyses showed anticonvulsants enhanced slow-wave sleep (p = .013)
  • This effect was identified as a class-specific influence on sleep architecture
  • The association was identified after adjustment for age, sex, and BMI with HC3 robust errors
  • Slow-wave sleep enhancement represents a distinct pattern from the effects observed with other psychotropic drug classes

Antipsychotics were specifically associated with reduced arousals during sleep.

  • Multivariable analyses showed antipsychotics reduced arousals (p = .004)
  • This class-specific effect was identified after adjustment for age, sex, and BMI
  • Reduced arousal index was also independently associated with greater cumulative psychotropic burden in dose-response analyses
  • Reduced arousals represent a distinct polysomnographic pattern compared to effects of other psychotropic classes

A dose-response relationship was observed between cumulative psychotropic burden and sleep architecture parameters.

  • Greater psychotropic burden was independently associated with longer REM latency (p = .029)
  • Greater psychotropic burden was independently associated with reduced arousal index (p = .001)
  • Cumulative psychotropic burden was analyzed as a continuous predictor in the statistical models
  • The dose-response relationship indicates effects compound as the number of concurrent agents grows

The study used a retrospective polysomnographic design drawing from a sleep laboratory database over a four-year period.

  • Sociodemographic and polysomnographic data were obtained from a sleep laboratory database between January 2018 and December 2021
  • Total sample included 60 non-psychotropic medication users and 61 psychotropic medication users who underwent hospital polysomnography and met all inclusion criteria
  • Statistical analysis included normality assessment and appropriate parametric or non-parametric tests for group comparisons
  • Multivariable general linear models adjusted for age, sex, and BMI with HC3 robust errors were used to evaluate associations

What This Means

This research suggests that common psychiatric medications — including antidepressants, antipsychotics, and anticonvulsants — each affect sleep in distinct and measurable ways. Using detailed overnight sleep studies (polysomnography) from a hospital database, researchers compared 61 people taking psychotropic medications to 60 people not taking them. People on psychiatric medications generally had less efficient sleep, took longer to fall asleep, and reached REM (dreaming) sleep much later in the night. Different drug classes had their own specific fingerprints: antidepressants dramatically delayed REM sleep and increased leg movement activity, anticonvulsants increased deep slow-wave sleep, and antipsychotics reduced the number of times people briefly woke up during the night. This research also suggests that the more psychiatric medications a person takes at the same time, the stronger these effects become. This 'cumulative burden' concept — that each additional medication adds to the total impact on sleep — was independently associated with even longer delays to REM sleep and further reductions in nighttime arousals. This matters because polysomnography is often used to diagnose sleep disorders, and these drug-related changes to sleep structure could be mistaken for signs of a sleep disorder or could mask one. Practically, this research suggests that clinicians interpreting sleep studies should consider not just whether a patient is on psychiatric medication, but how many medications they are taking simultaneously. The authors call for future prospective studies that also track dosage, drug levels in the blood, and effects on thinking and memory, since this retrospective study could not fully account for those factors.

Check Your Own Numbers

Upload your bloodwork. We'll cross-reference your results against this study and 4,700 others.

Upload Your Labs

Have a question about this study?

Citation

Alfaiate D, Silva P, Guerra P, Pinto N, Pereira A. (2026). Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study.. European journal of pharmacology. https://doi.org/10.1016/j.ejphar.2026.179292